4.7 Review

The immune escape mechanism of nasopharyngeal carcinoma

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Immunology

Spatiotemporal Adaptations of Macrophage and Dendritic Cell Development and Function

Antoine Roquilly et al.

Summary: Macrophages and conventional dendritic cells are crucial for maintaining tissue homeostasis, coordinating immune responses, and fighting against infections and cancer. They acquire spatiotemporal adaptations in response to different environmental challenges, but these adaptations can also lead to immunosuppression. Understanding their development and adaptation mechanisms can help harness their beneficial outcomes and minimize their adverse effects.

ANNUAL REVIEW OF IMMUNOLOGY (2022)

Article Oncology

EBV Infection in Epithelial Malignancies Induces Resistance to Antitumor Natural Killer Cells via F3-Mediated Platelet Aggregation

Xiaobing Duan et al.

Summary: This study reveals a mechanism by which EBV-associated epithelial malignancies escape NK-cell-mediated immune surveillance, providing a new target for improving NK-cell immunotherapy.

CANCER RESEARCH (2022)

Review Otorhinolaryngology

Circular RNAs: Functions and mechanisms in nasopharyngeal carcinoma

Wanpeng Li et al.

Summary: Nasopharyngeal carcinoma is a malignant epithelial tumor with a high incidence in southern China and Southeast Asia, while circRNAs, as single-stranded noncoding RNAs, have unclear expression patterns and clinical significance in NPC patients. They may serve as potential clinical biomarkers for diagnosis and prognosis.

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2022)

Article Multidisciplinary Sciences

EBV miRNAs BART11 and BART17-3p promote immune escape through the enhancer-mediated transcription of PD-L1

Jie Wang et al.

Summary: This study finds that EBV-miR-BART11 and EBV-miR-BART17-3p upregulate the expression of PD-L1 in EBV-associated cancers and elucidates the underlying regulatory mechanism, promoting tumor immune escape and providing potential targets for EBV-related tumor immunotherapy.

NATURE COMMUNICATIONS (2022)

Article Oncology

Epstein-Barr virus-induced ectopic CD137 expression helps nasopharyngeal carcinoma to escape immune surveillance and enables targeting by chimeric antigen receptors

Mukul Prasad et al.

Summary: This study identifies CD137 as a potential target for immunotherapy in non-keratinizing nasopharyngeal carcinoma (NPC), as its overexpression allows NPC to evade immune surveillance and promotes its growth and spread. CD137-specific chimeric antigen receptors on natural killer cells induce death in CD137(+) NPC cells, suggesting its potential as a therapeutic approach for NPC.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2022)

Review Oncology

B cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical outcome

Wolf H. Fridman et al.

Summary: B cells play a critical role in the tumor microenvironment, particularly within tertiary lymphoid structures (TLS). The presence of mature TLS, high density of B cells and plasma cells, and antibodies targeting tumor-associated antigens are associated with favorable clinical outcomes and response to immunotherapy. However, polyclonal B cell activation can lead to pro-inflammatory responses. Novel therapeutic approaches are being explored to enhance the development of TLS and anti-tumor B cells for cancer therapy.

NATURE REVIEWS CLINICAL ONCOLOGY (2022)

Article Oncology

TGF-β1-Mediated PD-L1 Glycosylation Contributes to Immune Escape via c-Jun/STT3A Pathway in Nasopharyngeal Carcinoma

Xue-Min Ma et al.

Summary: N-glycosylation of PD-L1 in nasopharyngeal carcinoma (NPC) is regulated by the TGF-beta 1 activated c-Jun/STT3A signaling pathway, which affects immune evasion and reduces the efficacy of cancer immunotherapy.

FRONTIERS IN ONCOLOGY (2022)

Review Oncology

Insight into LncRNA- and CircRNA-Mediated CeRNAs: Regulatory Network and Implications in Nasopharyngeal Carcinoma-A Narrative Literature Review

Senmiao Zhang et al.

Summary: This review summarizes the biological functions and clinical implications of long noncoding RNAs and circular RNAs as competitive endogenous RNAs in nasopharyngeal carcinoma (NPC). The imbalanced ceRNA networks derived from lncRNA/circRNA-miRNA-mRNA interaction are widely found to contribute to NPC development. Understanding the involvement of these ceRNAs networks provides new insights into the pathogenesis and treatment strategies of NPC.

CANCERS (2022)

Article Genetics & Heredity

Integrated analysis of bulk and single-cell RNA sequencing reveals the interaction of PKP1 and tumor-infiltrating B cells and their therapeutic potential for nasopharyngeal carcinoma

Yu-Mei Huang et al.

Summary: This study identified novel biomarkers involved in nasopharyngeal carcinoma (NPC) by integrating bulk and single-cell RNA sequencing data, and discovered that PKP1 and tumor-infiltrating lymphocyte-B cells (TIL-Bs) were promising therapeutic targets for NPC.

FRONTIERS IN GENETICS (2022)

Review Biochemistry & Molecular Biology

Emerging roles of lncRNA in Nasopharyngeal Carcinoma and therapeutic opportunities

Haihua Wang et al.

Summary: Nasopharyngeal carcinoma is a malignant tumor with specific ethnic and geographical distribution characteristics. Recent studies have shown that long non-coding RNAs play important regulatory roles in the development of nasopharyngeal carcinoma. In-depth understanding of abnormal lncRNAs may provide new insights into the pathogenesis of nasopharyngeal carcinoma and offer new approaches for early diagnosis and treatment.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2022)

Review Oncology

B7-H3: An Attractive Target for Antibody-based Immunotherapy

Filippos Kontos et al.

Summary: B7-H3, as a potential target for antibody-based immunotherapy, is overexpressed in malignant tissues and associated with poor prognosis. Although the receptor for B7-H3 remains unknown, various antibody-based strategies targeting B7-H3-expressing cancer cells have been developed, demonstrating potent antitumor activity in preclinical models. Ongoing clinical trials are evaluating the safety and efficacy of these strategies in patients, with the hope of enhancing the therapeutic efficacy of tumor immunity.

CLINICAL CANCER RESEARCH (2021)

Review Immunology

Cytokine-regulated Th17 plasticity in human health and diseases

Silvia Cerboni et al.

Summary: This review discusses how cytokines regulate Th17 cell plasticity, focusing on the regulation of lineage-specific transcription factors, chromatin remodelling and metabolism. Th17 cells play important roles in autoimmunity and cancer, and understanding Th17 plasticity may have potential implications for treating autoimmune and inflammatory diseases.

IMMUNOLOGY (2021)

Editorial Material Oncology

B cells and cancer

Victor Engelhard et al.

Summary: Tumor-infiltrating B cells work alongside T cells to combat tumors, controlling tumor growth through various mechanisms and showing a correlation with immunotherapy response.

CANCER CELL (2021)

Article Biochemistry & Molecular Biology

Neoantigen-driven B cell and CD4 T follicular helper cell collaboration promotes anti-tumor CD8 T cell responses

Can Cui et al.

Summary: The study found that the enrichment of TFH cell transcriptional signature in lung adenocarcinoma patients is correlated with GC B cell signature and prolonged survival. Interactions between tumor-specific TFH and GC B cells are crucial for tumor control and effector CD8 T cell function.
Review Oncology

Tumor-Infiltrating Natural Killer Cells

Beatriz Cozar et al.

Summary: NK cells play a crucial role in immune responses to tumors by killing target cells and producing cytokines, but they can become dysfunctional in the immunosuppressive tumor microenvironment. This article provides an overview of NK tumor infiltration and surveillance, as well as the mechanisms by which NK cells become dysfunctional.

CANCER DISCOVERY (2021)

Article Oncology

PBK phosphorylates MSL1 to elicit epigenetic modulation of CD276 in nasopharyngeal carcinoma

Meng-Yao Wang et al.

Summary: The study reveals a novel PBK/MSL1/CD276 signaling axis that may play a significant role in immune evasion in nasopharyngeal carcinoma and could be a potential target for cancer immunotherapy.

ONCOGENESIS (2021)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Oncology

Circular RNA TGFBR2 acts as a ceRNA to suppress nasopharyngeal carcinoma progression by sponging miR-107

Wanpeng Li et al.

Summary: In this study, it was found that miR-107 plays a crucial role in promoting proliferation and migration of NPC cells, while circTGFBR2 acts as a sponge for miR-107, leading to upregulation of TGFBR2 expression and suppression of NPC progression. These findings suggest that circTGFBR2 could serve as a novel tumor suppressive factor and potential therapeutic target for NPC patients.

CANCER LETTERS (2021)

Review Biochemistry & Molecular Biology

Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives

Xiaoqi Mao et al.

Summary: CAFs, as a crucial component of TME, play significant roles in promoting tumor growth, invasion, and metastasis. The interaction between CAFs and tumor cells, as well as immune cells in TIME, is critical for tumor progression.

MOLECULAR CANCER (2021)

Article Multidisciplinary Sciences

Comprehensive single-cell sequencing reveals the stromal dynamics and tumor-specific characteristics in the microenvironment of nasopharyngeal carcinoma

Lanqi Gong et al.

Summary: The authors used single-cell sequencing to investigate the microenvironment of nasopharyngeal cancer and identified tumor-specific signatures in five stromal clusters of cells that may influence patient survival.

NATURE COMMUNICATIONS (2021)

Article Multidisciplinary Sciences

Tumour heterogeneity and intercellular networks of nasopharyngeal carcinoma at single cell resolution

Yang Liu et al.

Summary: Nasopharyngeal carcinoma is characterized by a heterogeneous microenvironment, with single cell sequencing revealing different cell types including immune-suppressive T regulatory, tolerogenic dendritic, and exhausted CD8 T cells. Intensive inter-cell interactions are observed, potentially promoting the formation of an immune-suppressive niche in the TME.

NATURE COMMUNICATIONS (2021)

Review Oncology

The Role of EBV-Encoded LMP1 in the NPC Tumor Microenvironment: From Function to Therapy

Angela Kwok-Fung Lo et al.

Summary: LMP1, as a critical protein in EBV infection, plays an important role in the development of NPC by activating multiple pathways. Targeting LMP1 protein for treatments may be a novel therapeutic strategy for EBV-driven malignancies.

FRONTIERS IN ONCOLOGY (2021)

Review Oncology

The Evolving Epidemiology of Nasopharyngeal Carcinoma

Ellen T. Chang et al.

Summary: This review highlights the recent epidemiologic literature on nasopharyngeal carcinoma, focusing on geographic distribution, the involvement of EBV, and the association with Chinese-style salt-preserved fish. New findings suggest a diminished role of salt-preserved fish, a significant impact of EBV genetic sequence variation, and potential effects of oral health and microbiome. Other studies have revealed associations with infectious mononucleosis and genetic variations in response to EBV infection.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2021)

Article Oncology

MicroRNA-483-5p Predicts Poor Prognosis and Promotes Cancer Metastasis by Targeting EGR3 in Nasopharyngeal Carcinoma

Xi-Zhao Li et al.

Summary: MiR-483-5p is highly expressed in NPC and is associated with poor prognosis of NPC patients. Inhibiting its expression can suppress the migration and invasion of NPC cells, with its target identified as EGR3, the downregulation of which enhances the migration and invasion capacities of NPC cells.

FRONTIERS IN ONCOLOGY (2021)

Article Oncology

Lymphocyte activating gene 3 protein expression in nasopharyngeal carcinoma is correlated with programmed cell death-1 and programmed cell death ligand-1, tumor-infiltrating lymphocytes

Fan Luo et al.

Summary: This study found that high expression of LAG-3 in NPC patients was associated with poorer disease-free survival, along with PD-1 and PD-L1 expression. This suggests that LAG-3 may serve as a promising therapeutic target for NPC treatment.

CANCER CELL INTERNATIONAL (2021)

Article Oncology

Epstein-Barr Virus-Encoded Circular RNA CircBART2.2 Promotes Immune Escape of Nasopharyngeal Carcinoma by Regulating PD-L1

Junshang Ge et al.

Summary: This study demonstrates that circBART2.2 binding to RIG-I is crucial for regulating PD-L1 and subsequent immune escape in nasopharyngeal carcinoma.

CANCER RESEARCH (2021)

Article Medicine, Research & Experimental

An open-label, nonrandomized, phase Ib feasibility study of cusatuzumab in patients with nasopharyngeal carcinoma

Astrid De Meulenaere et al.

Summary: The study evaluated the safety and activity of cusatuzumab in advanced nasopharyngeal carcinoma with partial treatment information from some patients, showing limited efficacy of cusatuzumab monotherapy for patients with nasopharyngeal carcinoma.

CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2021)

Review Oncology

Nasopharyngeal carcinoma: an evolving paradigm

Kenneth C. W. Wong et al.

Summary: Over the past three decades, significant progress has been made in understanding the molecular biology and treatment of nasopharyngeal carcinoma (NPC), an Epstein-Barr virus (EBV)-associated cancer. Technological advances have led to the introduction of proton therapy and other contemporary radiotherapy approaches, with continued efforts to determine the optimal sequencing of chemotherapy with radiotherapy through decades of clinical trials.

NATURE REVIEWS CLINICAL ONCOLOGY (2021)

Article Multidisciplinary Sciences

Whole-genome profiling of nasopharyngeal carcinoma reveals viral-host co-operation in inflammatory NF-κB activation and immune escape

Jeff P. Bruce et al.

Summary: This study performed whole-genome sequencing for 70 NPCs with EBV gene expression, revealing the collaborative effects of genomic aberrations and EBV infection in NPC development, as well as the impact of EBV-mediated effects on NF-kappa B activation and immune escape. Furthermore, homozygous MTAP deletions were identified as a potential target for therapy in a subset of NPC cases.

NATURE COMMUNICATIONS (2021)

Review Cell Biology

Mast Cells: A New Frontier for Cancer Immunotherapy

Jake N. Lichterman et al.

Summary: Mast cells, historically associated with allergies and autoimmune disorders, have now shown to play significant roles in cancer immunity. Targeting mast cells by modulating their activation, numbers, and secreted mediators could potentially improve cancer treatment outcomes.
Article Medicine, Research & Experimental

Neoantigen landscape in metastatic nasopharyngeal carcinoma

Mei Lin et al.

Summary: By sequencing samples from 26 nasopharyngeal carcinoma patients, it was found that NPC has a higher neoantigen load compared to other cancers. Neoantigen depletion was more severe in metastatic sites, with the reduction occurring during metastasis.

THERANOSTICS (2021)

Article Biochemistry & Molecular Biology

Viral IL-10 promotes cell proliferation and cell cycle progression via JAK2/STAT3 signaling pathway in nasopharyngeal carcinoma cells

Yanxin Ren et al.

BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY (2020)

Article Medicine, Research & Experimental

In vitro evaluation of the therapeutic effectiveness of EBV-LMP2 recombinant adenovirus vaccine in nasopharyngeal carcinoma

Yuyang Ge et al.

BIOMEDICINE & PHARMACOTHERAPY (2020)

Review Pharmacology & Pharmacy

Emerging therapeutic targets for nasopharyngeal carcinoma: opportunities and challenges

Valentin Baloche et al.

EXPERT OPINION ON THERAPEUTIC TARGETS (2020)

Review Oncology

Oncogenic Properties of the EBV ZEBRA Protein

Diego Germini et al.

CANCERS (2020)

Review Immunology

Phenotypes, Functions, and Clinical Relevance of Regulatory B Cells in Cancer

Jin Shang et al.

FRONTIERS IN IMMUNOLOGY (2020)

Review Chemistry, Medicinal

Chemotherapy and chemo-resistance in nasopharyngeal carcinoma

Shuzhen Guan et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)

Editorial Material Immunology

Tumor-Derived PGE2 Gives NK Cells a Headache

Nelson H. Knudsen et al.

IMMUNITY (2020)

Article Oncology

Immune Phenotypes of Nasopharyngeal Cancer

Johan S. Nilsson et al.

CANCERS (2020)

Review Biochemistry & Molecular Biology

Advances in targeted therapy mainly based on signal pathways for nasopharyngeal carcinoma

Yuanbo Kang et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)

Review Immunology

B cells, plasma cells and antibody repertoires in the tumour microenvironment

George Sharonov et al.

NATURE REVIEWS IMMUNOLOGY (2020)

Article Oncology

Current Treatment Landscape of Nasopharyngeal Carcinoma and Potential Trials Evaluating the Value of Immunotherapy

Quynh Thu Le et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2019)

Review Biochemistry & Molecular Biology

TGF--Mediated Epithelial-Mesenchymal Transition and Cancer Metastasis

Yang Hao et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Article Medicine, Research & Experimental

IL-6/JAK1 pathway drives PD-L1 Y112 phosphorylation to promote cancer immune evasion

Li-Chuan Chan et al.

JOURNAL OF CLINICAL INVESTIGATION (2019)

Review Oncology

MicroRNAs as Therapeutic Targets in Nasopharyngeal Carcinoma

Sumei Wang et al.

FRONTIERS IN ONCOLOGY (2019)

Article Immunology

Mitochondrial fragmentation limits NK cell-based tumor immunosurveillance

Xiaohu Zheng et al.

NATURE IMMUNOLOGY (2019)

Review Oncology

Biological Consequences of MHC-II Expression by Tumor Cells in Cancer

Margaret L. Axelrod et al.

CLINICAL CANCER RESEARCH (2019)

Review Biochemistry & Molecular Biology

Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape

Xianjie Jiang et al.

MOLECULAR CANCER (2019)

Article Microbiology

Epstein-Barr Virus and the Human Leukocyte Antigen Complex

Qingxue Li et al.

CURRENT CLINICAL MICROBIOLOGY REPORTS (2019)

Article Otorhinolaryngology

Detailed analysis of inflammatory cell infiltration and the prognostic impact on nasopharyngeal carcinoma

Juan Lu et al.

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2018)

Article Oncology

Exosomal miR-9 inhibits angiogenesis by targeting MDK and regulating PDK/AKT pathway in nasopharyngeal carcinoma

Juan Lu et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)

Review Immunology

Plasmacytoid dendritic cell in immunity and cancer

Dana Mitchell et al.

JOURNAL OF NEUROIMMUNOLOGY (2018)

Article Microbiology

Ephrin receptor A2 is an epithelial cell receptor for Epstein-Barr virus entry

Hua Zhang et al.

NATURE MICROBIOLOGY (2018)

Article Biochemistry & Molecular Biology

NKG2A Blockade Potentiates CD8 T Cell Immunity Induced by Cancer Vaccines

Nadine van Montfoort et al.

Review Immunology

Dendritic Cells and CD8 T Cell Immunity in Tumor Microenvironment

Chunmei Fu et al.

FRONTIERS IN IMMUNOLOGY (2018)

Article Immunology

Gene sharing between Epstein-Barr virus and human immune response genes

David H. Dreyfus

IMMUNOLOGIC RESEARCH (2017)

Review Oncology

BART miRNAs: an unimaginable force in the development of nasopharyngeal carcinoma

Youhong Wang et al.

EUROPEAN JOURNAL OF CANCER PREVENTION (2017)

Review Immunology

Tumor-associated macrophages: implications in cancer immunotherapy

Amy J. Petty et al.

IMMUNOTHERAPY (2017)

Review Biology

Epstein-Barr virus infection and nasopharyngeal carcinoma

Sai Wah Tsao et al.

PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2017)

Article Immunology

Dual Role of Fas/FasL-Mediated Signal in Peripheral Immune Tolerance

Akiko Yamada et al.

Frontiers in Immunology (2017)

Article Biotechnology & Applied Microbiology

Association of Single-Nucleotide Polymorphisms in DC-SIGN with Nasopharyngeal Carcinoma Susceptibility

Sisi Li et al.

DISEASE MARKERS (2017)

Review Chemistry, Medicinal

Diverse macrophages polarization in tumor microenvironment

Inmoo Rhee

ARCHIVES OF PHARMACAL RESEARCH (2016)

Review Pharmacology & Pharmacy

Therapeutic targeting of CD70 and CD27

Harald Wajant

EXPERT OPINION ON THERAPEUTIC TARGETS (2016)

Review Immunology

Roles of regulatory T cells in cancer immunity

Yoshiko Takeuchi et al.

INTERNATIONAL IMMUNOLOGY (2016)

Review Medicine, General & Internal

Nasopharyngeal carcinoma

Melvin L. K. Chua et al.

LANCET (2016)

Article Biochemistry & Molecular Biology

TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathway

Sebastien Viel et al.

SCIENCE SIGNALING (2016)

Article Multidisciplinary Sciences

Structural basis for Epstein-Barr virus host cell tropism mediated by gp42 and gHgL entry glycoproteins

Karthik Sathiyamoorthy et al.

NATURE COMMUNICATIONS (2016)

Article Biochemistry & Molecular Biology

TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathway

Sebastien Viel et al.

SCIENCE SIGNALING (2016)

Article Oncology

A new prognostic histopathologic classification of nasopharyngeal carcinoma

Hai-Yun Wang et al.

CHINESE JOURNAL OF CANCER (2016)

Article Biochemistry & Molecular Biology

Interleukin-10 polymorphisms and nasopharyngeal carcinoma risk: a meta-analysis

Y. -F. Yu et al.

GENETICS AND MOLECULAR RESEARCH (2015)

Review Biotechnology & Applied Microbiology

Th17 Cell Plasticity and Functions in Cancer Immunity

Leslie Guery et al.

BIOMED RESEARCH INTERNATIONAL (2015)

Article Biochemistry & Molecular Biology

TGFβR2 is a major target of miR-93 in nasopharyngeal carcinoma aggressiveness

Xiaoming Lyu et al.

MOLECULAR CANCER (2014)

Review Immunology

IL-6 and related cytokines as the critical lynchpins between inflammation and cancer

Koji Taniguchi et al.

SEMINARS IN IMMUNOLOGY (2014)

Article Virology

Human herpesvirus 8 glycoprotein B binds the entry receptor DC-SIGN

Heather R. Hensler et al.

VIRUS RESEARCH (2014)

Review Pathology

The Role and Regulation of Human Th17 Cells in Tumor Immunity

Jian Ye et al.

AMERICAN JOURNAL OF PATHOLOGY (2013)

Review Biochemistry & Molecular Biology

Microenvironmental regulation of tumor progression and metastasis

Daniela F. Quail et al.

NATURE MEDICINE (2013)

Review Virology

BamHI-A rightward frame 1, an Epstein-Barr virus-encoded oncogene and immune modulator

Eveline K. Hoebe et al.

REVIEWS IN MEDICAL VIROLOGY (2013)

Review Oncology

Role of EBER and BARF1 in nasopharyngeal carcinoma (NPC) tumorigenesis

Kenzo Takada

SEMINARS IN CANCER BIOLOGY (2012)

Review Oncology

Role of EBNA1 in NPC tumourigenesis

Lori Frappier

SEMINARS IN CANCER BIOLOGY (2012)

Review Microbiology

Fusing structure and function: a structural view of the herpesvirus entry machinery

Sarah A. Connolly et al.

NATURE REVIEWS MICROBIOLOGY (2011)

Article Immunology

Tumor Microenvironments Direct the Recruitment and Expansion of Human Th17 Cells

Xinming Su et al.

JOURNAL OF IMMUNOLOGY (2010)

Review Immunology

Innate immunity to virus infection

Osamu Takeuchi et al.

IMMUNOLOGICAL REVIEWS (2009)

Article Immunology

Regulatory T cells and EBV associated malignancies

Jiang Li et al.

INTERNATIONAL IMMUNOPHARMACOLOGY (2009)

Article Virology

Epstein-Barr Virus LF2: an Antagonist to Type I Interferon

Liguo Wu et al.

JOURNAL OF VIROLOGY (2009)

Article Multidisciplinary Sciences

Host shutoff during productive Epstein-Barr virus infection is mediated by BGLF5 and may contribute to immune evasion

Martin Rowe et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)

Article Multidisciplinary Sciences

Resting B cells as a transfer vehicle for Epstein-Barr virus infection of epithelial cells

CD Shannon-Lowe et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)

Article Oncology

Variation of the killer cell immunoglobulin-like receptors and HLA-C genes in nasopharyngeal carcinoma

MB Kovacic et al.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2005)

Review Oncology

Epstein-Barr virus: 40 years on

LS Young et al.

NATURE REVIEWS CANCER (2004)

Article Biochemistry & Molecular Biology

Epstein-Barr virus infection of polarized tongue and nasopharyngeal epithelial cells

SM Tugizov et al.

NATURE MEDICINE (2003)

Review Multidisciplinary Sciences

Inflammation and cancer

LM Coussens et al.

NATURE (2002)

Article Oncology

Tumor-induced death of immune cells: its mechanisms and consequences

TL Whiteside

SEMINARS IN CANCER BIOLOGY (2002)

Review Immunology

The B7-CD28 superfamily

AH Sharpe et al.

NATURE REVIEWS IMMUNOLOGY (2002)

Article Biotechnology & Applied Microbiology

Roles of Epstein-Barr virus glycoproteins gp350 and gp25 in the infection of human epithelial cells

S Maruo et al.

JOURNAL OF GENERAL VIROLOGY (2001)